Description

BPC-157 has undergone a great deal of research because its healing abilities extend well
beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance
angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory
response, and protect against oxidative stress. The peptide has shown benefits in animal models
with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries
and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite
high.
BPC-157 is a Penta decapeptide (15 amino acids in length) derivative of the much
larger, naturally occurring protein known as body protection compound or BPC. The original
BPC peptide was isolated from human stomach contents where it is thought to play an
important role in maintaining the integrity of the stomach wall against the erosive effects of
stomach acid. Research on the protein revealed that the majority of its tissue-healing effects
are contained within a small 15-amino-acid section that is now referred to as BPC-
157. This smaller fragment is easier to produce synthetically and has become of interest in
research settings
BPC-157 has garnered a great deal of research setting because its healing abilities extend
well beyond the lining of the stomach. Studies in animal models indicate that BP- 157 can
enhanced blood vessel formation (angiogenesis), promote wound healing, stimulate
collagen synthesis, modulate the inflammatory response, and protect against oxidative
stress. The peptide has shown benefits in animal models of inflammatory bowel disease, GI
ulcers, musculoskeletal injury, heart damage, eye injury, and even neurological injury
BPC-157 can be administered via SubQ admin or orally for research with lab animals. The
oral bioavailability of BPC-157 is quite high. Though most research featuring oral
administration of BPC-157 has focused on the peptide’s effects in the GI system, it can be
absorbed and provide impact in other tissues. Interest in the oral benefits of BPC-157 has
steadily increased given the therapeutic potential of the peptide and the rising incidences of
both inflammatory bowel disease and heart disease.